Neuren Pharmaceuticals Ltd. (NURPF)
14.28
+0.34
(+2.42%)
USD |
OTCM |
Oct 02, 16:00
Neuren Pharmaceuticals Cash from Operations (TTM) : 6.411M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.411M |
| December 31, 2025 | 82.18M |
| June 30, 2025 | 87.46M |
| December 31, 2024 | -7.450M |
| June 30, 2024 | 77.86M |
| December 31, 2023 | 121.69M |
| June 30, 2023 | 36.62M |
| December 31, 2022 | 2.126M |
| June 30, 2022 | -6.978M |
| December 31, 2021 | -7.539M |
| June 30, 2021 | -6.860M |
| December 31, 2020 | -5.498M |
| June 30, 2020 | -5.993M |
| December 31, 2019 | -8.192M |
| June 30, 2019 | 1.947M |
| December 31, 2018 | 4.456M |
| June 30, 2018 | -4.643M |
| December 31, 2017 | -4.267M |
| June 30, 2017 | -5.696M |
| December 31, 2016 | -9.157M |
| June 30, 2016 | -12.02M |
| Date | Value |
|---|---|
| December 31, 2015 | -9.471M |
| June 30, 2015 | -6.990M |
| December 31, 2014 | -5.764M |
| June 30, 2014 | -6.475M |
| December 31, 2013 | -6.546M |
| June 30, 2013 | -5.204M |
| December 31, 2012 | -3.032M |
| June 30, 2012 | -2.804M |
| December 31, 2011 | -3.305M |
| June 30, 2011 | -2.342M |
| December 31, 2010 | -2.725M |
| June 30, 2010 | -1.471M |
| December 31, 2009 | -1.112M |
| June 30, 2009 | -3.259M |
| December 31, 2008 | -7.816M |
| June 30, 2008 | -10.71M |
| December 31, 2007 | -9.524M |
| June 30, 2007 | -7.852M |
| December 31, 2006 | -6.620M |
| June 30, 2006 | -6.258M |
| December 31, 2005 | -6.222M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Percheron Therapeutics Ltd. | -3.485M |
| Starpharma Holdings Ltd. | -2.255M |
| Mayne Pharma Group Ltd. | 10.97M |
| Acrux Ltd. | 0.7159M |
| Zelira Therapeutics Ltd. | -3.113M |